Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 41 Show results per page	View Search Criteria \| Help With Results


1.		Reduced Intensity Transplant Using Extracorporeal Photopheresis

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and under				Other				ECP RIT NCT00179790


2.		Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				21 and under				Other				BMT 0499 Solid NCT00179816


3.		Aerosol L9-NC and Temozolomide in Ewing's Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				10 and over				Other				2005-0889 NCT00492141


4.		Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				10 and over				Pharmaceutical / Industry				A4021020 NCT00560235

Last Modified: 8/23/2008 First Published: 7/1/2001


5.		Phase II Pilot Study of High-Dose Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation and Immunotherapy With Activated T Cells, Interleukin-2, and Sargramostim (GM-CSF) in Patients With Stage IIIB or IV Breast Cancer or Other Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				WSU-2007-033 NCT00020722, RWMC-0634246

Last Modified: 1/18/2008 First Published: 10/1/2002


6.		Phase II Pilot Study of Induction Chemotherapy Followed By Allogeneic/Syngeneic Peripheral Blood Stem Cell Transplantation in Patients With High-Risk, Recurrent Pediatric Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				4 to 35				NCI				NCI-02-C-0259H NCT00047372

Last Modified: 4/22/2008 First Published: 11/20/2003


7.		Phase II Study of Sequential Gemcitabine and Docetaxel in Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing’s Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				4 and over				NCI				SARC003 NCT00073983, NCI-04-C-0001, AEWS0421, MAYO-79-2003

Last Modified: 6/10/2008 First Published: 5/28/2004


8.		Phase II Study of Umbilical Cord Blood as a Source of Hematopoietic Stem Cells for Transplantation in Children With Malignant or Non-Malignant Diseases

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				21 and under				Other				PSCI-2003-232 NCT00084695


9.		Radiation Therapy to Treat Musculoskeletal Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				25 and under				Other				RTSARC NCT00186992

Last Modified: 11/2/2007 First Published: 7/23/2006


10.		Phase II Study of a Myeloablative Regimen Comprising Busulfan, Melphalan, and Thiotepa Followed By T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation in Patients With High-Risk Tumors of the Ewing's Family

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				40 and under				Other				MSKCC-05059 NCT00357396

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute